Hyera Kim
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery.
Journal: Cancers
Published: February 06, 2026
Dual Biomarker Combining DNA Damage Repair Gene Mutations and PD-L1 Expression for Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer.
Journal: Anticancer research
Published: February 14, 2023
Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer.
Journal: Oncology
Published: August 11, 2022
ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy.
Journal: In vivo (Athens, Greece)
Published: October 12, 2020
Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
Journal: BMC gastroenterology
Published: July 04, 2020
Circulating Tumor Cells Enumerated by a Centrifugal Microfluidic Device as a Predictive Marker for Monitoring Ovarian Cancer Treatment: A Pilot Study.
Journal: Diagnostics (Basel, Switzerland)
Published: March 17, 2020
Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells.
Journal: International journal of molecular sciences
Published: March 16, 2020
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
Journal: BMC cancer
Published: February 12, 2020
Last Updated: 09/26/2026